Skip to main content
Contact
Site Search
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Press Releases
Home
>
News/Events
>
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
12/21/2015
Momenta Resumes Patient Enrollment in the Necuparanib (MOM-M402-103) Phase 2 Study
Download
PDF format download (opens in new window)
12/21/2015
Baxalta and Momenta Announce M923, a Proposed HUMIRA (adalimumab) Biosimilar, Met Primary Endpoint in Pharmacokinetic Study
Download
PDF format download (opens in new window)
12/07/2015
Momenta Pharmaceuticals Appoints Matthew P. Ottmer as Chief Operating Officer
Download
PDF format download (opens in new window)
11/13/2015
Momenta Announces Temporary Pause of Patient Enrollment in the Necuparanib (MOM-M402-103) Phase 2 Study
Download
PDF format download (opens in new window)
11/10/2015
Momenta Pharmaceuticals Announces U.S. Court of Appeals Decision to Remand Enoxaparin Case Back to District Court
Download
PDF format download (opens in new window)
11/06/2015
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
11/04/2015
Momenta Pharmaceuticals Reports Third Quarter 2015 Financial Results
Download
PDF format download (opens in new window)
10/28/2015
Momenta Pharmaceuticals to Webcast Presentation at the Credit Suisse 24th Annual Healthcare Conference
Download
PDF format download (opens in new window)
10/26/2015
Momenta Pharmaceuticals Announces Publication of Two Glatopa (glatiramer acetate injection) Manuscripts
Download
PDF format download (opens in new window)
10/21/2015
Momenta Pharmaceuticals Announces Date of Third Quarter 2015 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
10/05/2015
Baxalta and Momenta Announce Initiation of Pivotal Clinical Trial for M923, a Biosimilar Version of HUMIRA (adalimumab)
Download
PDF format download (opens in new window)
10/01/2015
Momenta Presents Three Glatopa (glatiramer acetate injection) Posters at ECTRIMS 2015 Meeting
Download
PDF format download (opens in new window)
09/18/2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Download
PDF format download (opens in new window)
09/03/2015
Momenta Pharmaceuticals to Webcast Presentation at the Morgan Stanley Global Healthcare Conference
Download
PDF format download (opens in new window)
08/04/2015
Momenta Pharmaceuticals Reports Second Quarter 2015 Financial Results
Download
PDF format download (opens in new window)
07/21/2015
Momenta Pharmaceuticals Announces Date of Second Quarter 2015 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
06/25/2015
Momenta Pharmaceuticals Announces CFO Retirement and Succession Plan
Download
PDF format download (opens in new window)
06/18/2015
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Download
PDF format download (opens in new window)
06/18/2015
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Download
PDF format download (opens in new window)
06/04/2015
Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs at EULAR 2015
Download
PDF format download (opens in new window)
06/01/2015
Momenta Pharmaceuticals to Present New Data From Phase 1 Trial of Necuparanib in Patients With Pancreatic Cancer
Download
PDF format download (opens in new window)
05/26/2015
Momenta Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
05/19/2015
Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
05/18/2015
Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
05/18/2015
Momenta Pharmaceuticals Announces Data Presentation on Necuparanib (M402) at the 2015 ASCO Annual Meeting
Download
PDF format download (opens in new window)
05/12/2015
Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference
Download
PDF format download (opens in new window)
05/06/2015
Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference
Download
PDF format download (opens in new window)
05/01/2015
Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 40th Annual Health Care Conference
Download
PDF format download (opens in new window)
05/01/2015
Momenta Pharmaceuticals Reports First Quarter 2015 Financial Results
Download
PDF format download (opens in new window)
04/20/2015
Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting
Download
PDF format download (opens in new window)
04/17/2015
Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting
Download
PDF format download (opens in new window)
04/16/2015
Momenta Pharmaceuticals Announces Conference Call Details Regarding FDA Approval for Glatopa(TM) (glatiramer acetate injection)
Download
PDF format download (opens in new window)
04/16/2015
Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Download
PDF format download (opens in new window)
04/15/2015
Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
03/02/2015
Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialylated IVIg Drug Candidate in PNAS
Download
PDF format download (opens in new window)
02/18/2015
Momenta Pharmaceuticals to Webcast Presentation at Cowen and Company's 35th Annual Health Care Conference
Download
PDF format download (opens in new window)
02/17/2015
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results
Download
PDF format download (opens in new window)
02/03/2015
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
01/29/2015
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
01/21/2015
Momenta Pharmaceuticals Announces Supreme Court Decision to Remand Generic Copaxone(R) Case Back to CAFC
Download
PDF format download (opens in new window)